Methods and compositions for the prevention and treatment of sepsis
CA 2524534 C · Owner: Tanox, Inc. · Inventors: Fung, Sek Chung; Mollnes, Tom Eirik
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for preventing or treating sepsis by administering in conjunction a sepsis preventing or treating amount of one or more complement inhibitors and a sepsis preventing or treating amount of one or more CD14 pathway inhibitors to a patient. The complement inhibitors are preferably antibodies that bind to and inhibit complement proteins such as C5a and the CD14 pathway inhibitors are preferably antibodies that bind to and inhibit CD14 pathway components such as CD14 and LPS.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 14, 2004 and granted December 11, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 14, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 14, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.